← The Wire
GYRENasdaq
GYRE THERAPEUTICS, INC.
Pharmaceutical Preparations · DE · CIK 1124105
Develops and commercializes small-molecule therapies for organ fibrosis and inflammatory diseases
red 8-K · 90d
$575M
Market cap
$6.45
Last close
+2.5%
1D
+5.2%
5D
80K
Volume
Price · last 39 sessions-18.6%
May 4L $5.56 · H $8.04Jun 29
386
Total filings
Jun 16, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 8, 202610-Q10-QNov 7, 202510-Q10-QAug 11, 202510-Q10-QMay 9, 202510-Q10-QNov 13, 202410-Q10-QAug 13, 202410-Q10-QMay 13, 202410-Q10-QOct 26, 202310-Q10-QAug 14, 202310-Q10-QMay 15, 202310-Q10-QNov 14, 202210-Q10-QAug 15, 202210-Q10-QMay 9, 202210-Q10-QNov 12, 202110-Q10-QAug 5, 202110-Q10-QMay 6, 202110-Q10-QNov 5, 202010-Q10-QAug 6, 202010-Q10-QMay 11, 202010-Q10-QNov 7, 201910-Q10-QAug 1, 201910-Q10-QMay 2, 201910-Q10-QNov 1, 201810-Q10-QAug 2, 201810-Q10-QMay 3, 201810-Q10-QNov 2, 201710-Q10-QAug 3, 201710-Q10-QMay 11, 201710-Q10-QNov 3, 201610-Q10-QAug 4, 201610-QFORM 10-QMay 5, 201610-QFORM 10-QNov 5, 201510-QFORM 10-QJul 31, 201510-QFORM 10-QMay 7, 201510-Q10-QNov 6, 201410-QFORM 10-QAug 7, 201410-Q10-QMay 8, 201410-QFORM 10-QNov 6, 201310-QFORM 10-QAug 7, 201310-QFORM 10-QMay 8, 2013
Similar companies
Comparable business profile · signals at a glance